Introduction
Material and methods
The viral aetiology of genital warts has now been well established by the presence of virus particles with typical human wart virus morphology (Dunn and Ogilvie, 1968; Oriel and Almeida, 1970) in these lesions. However, there is no evidence as yet of antigenic identity between the viruses found in different clinical types of wart in man (Almeida et al., 1969) and very few studies have been undertaken on specific immunity to human papilloma virus (HPV) in patients with genital warts. Most studies carried out on humoral immunity have been on patients suffering from skin warts (Ogilvie, 1970; Cubie, 1972; Pyrhonen and Penttinen, 1972) and specific cellular immunity studies have been performed using only in vitro tests (Morison, 1974; Ivanyi and Morison, 1976; Lee and Eiseinger, 1976) . This study was therefore aimed at determining the levels of specific humoral and cellular immunity in patients with genital warts before and after an in vivo test (intradermal test), using purified, inactivated HPV prepared from plantar warts, and comparing them with results obtained in a normal infected population (Thivolet et al., 1977) . Pass and Marcus (1973) and inactivated with 0 4% formalin, dialysed against phosphate buffer solution (PBS), and diluted to approximately 1010 particles per 0 1 ml (5 ,ug proteins). Controls were set up according to a method previously described (Thivolet et al., 1977) (Fig. 1 (IF) tests were then performed as described by Genner (1971) (Fig. 2) . In these tests sheep antihuman IgG and antihuman IgM conjugates (Behring-Hoechst) were used after absorption and dilution. Frozen sections of plantar warts, which showed specific nuclear fluorescence with a rabbit HPV antiserum (Viac et al., 1977b) were used to detect antibodies in the patients' sera. The specificity of the IF test was shown by the absence of staining in a preimmune rabbit serum and in human sera derived from children under the age of five years, who did not have warts. Sections of normal adult skin, exposed to the positive sera, also failed to yield
fluorescence. All sera were tested at a dilution of I :10 and slides were viewed with a Leitz fluorescence microscope (epi-illumination Orthoplan). (Table 3) . (Morison, 1974; Ivanyi and Morison, 1976) , but there is much controversy regarding the significance of these tests (Lee and Eiseinger, 1976) and, in general, patients with anogenital warts were excluded from these studies (Morison, 1974) . Other authors (Maderna, 1934; Biberstein, 1944) tested skin hypersensitivity in patients with genital warts, but they used a saline extract of wart tissue, rather than purified HPV.
In this study, cellular immunity to wart virus has been tested directly by an IDT, using purified inactivated HPV. As already shown, the skin test we used seemed to be specific and sensitive in preliminary sera (Thivolet et al., 1977) . The incidence of positive IDT in patients with genital warts was as high as in patients with plantar warts and showed the existence of a cell-mediated immunity to HPV within these patients. Serological studies have demonstrated the existence of wart virus specific antibodies in the sera of patients with genital warts (Ogilvie, 1970 (Ogilvie, 1970) . The seroconversion observed after the skin test (27 6-75 %), especially in patients with a positive skin test (36-9-86.6%) was in favour of wart virus specific antibodies present at low levels in many cases.
Thus, genital warts induced a specific immune response to HPV: a cell mediated immunity which seemed to play a major role in the cure of skin warts (Viac et al., 1977a) and, less frequently, wart virus specific antibodies, which increased significantly after the skin test, thus acting as a booster effect.
Our results were similar to those obtained with patients bearing skin warts (Viac et al., 1977b) 
